Research Paper Volume 15, Issue 7 pp 2734—2771

Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma


Figure 15. Analysis of the docking structures, pathways, and drug sensitivity of TSEN54 and its interacting genes. Detailed interaction structures between (A) TSEN54 and CSNK2B and (B) TSEN54 and ATM. The key residues of TSEN54 are shown in light pink, CSNK2B in aquamarine, and ATM in blue-white. The hydrogen bonds are shown as yellow dashed lines and the distance between two atoms is marked. (C) Cancer-related pathways of TSEN54 and its interacting genes are presented in the form of a global percentage. (D) Drug susceptibility analysis of TSEN54 and its interacting genes based on the GDSC database is presented as a bubble chart.